Tudor Investment Corp’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$527K Buy
+46,314
New +$502K ﹤0.01% 2782
2025
Q2
Sell
-99,876
Closed -$938K 3208
2025
Q1
$938K Buy
99,876
+80,038
+403% +$841K ﹤0.01% 1860
2024
Q4
$182K Sell
19,838
-115,929
-85% -$852K ﹤0.01% 2860
2024
Q3
$1.06M Sell
135,767
-3,599
-3% -$26K ﹤0.01% 1582
2024
Q2
$843K Buy
139,366
+38,163
+38% +$235K ﹤0.01% 1547
2024
Q1
$594K Buy
101,203
+1,823
+2% +$10.8K ﹤0.01% 1568
2023
Q4
$779K Buy
99,380
+344
+0.3% +$2.39K 0.01% 1568
2023
Q3
$724K Buy
99,036
+51,406
+108% +$428K 0.01% 1484
2023
Q2
$497K Buy
47,630
+23,677
+99% +$228K 0.01% 1718
2023
Q1
$248K Sell
23,953
-32,862
-58% -$421K ﹤0.01% 2055
2022
Q4
$782K Sell
56,815
-11,626
-17% -$162K 0.02% 1284
2022
Q3
$1.4M Sell
68,441
-11,515
-14% -$253K 0.03% 712
2022
Q2
$1.55M Sell
79,956
-2,313
-3% -$47.4K 0.04% 629
2022
Q1
$1.77M Buy
82,269
+60,484
+278% +$1.37M 0.04% 615
2021
Q4
$601K Buy
21,785
+14,022
+181% +$387K 0.01% 1324
2021
Q3
$201K Buy
+7,763
New +$208K ﹤0.01% 2311
2019
Q4
Sell
-23,920
Closed -$441K 1132
2019
Q3
$441K Sell
23,920
-33,087
-58% -$647K 0.02% 750
2019
Q2
$1.12M Buy
+57,007
New +$1.16M 0.03% 486
2018
Q1
Sell
-30,168
Closed -$502K 982
2017
Q4
$502K Sell
30,168
-9,273
-24% -$158K 0.01% 602
2017
Q3
$674K Sell
39,441
-8,129
-17% -$137K 0.02% 544
2017
Q2
$771K Buy
47,570
+19,269
+68% +$305K 0.02% 414
2017
Q1
$491K Buy
28,301
+3,327
+13% +$55.6K 0.02% 698
2016
Q4
$421K Sell
24,974
-30,385
-55% -$507K 0.01% 809
2016
Q3
$971K Buy
+55,359
New +$898K 0.02% 418
2016
Q1
Sell
-10,139
Closed -$123K 1717
2015
Q4
$123K Sell
10,139
-1,600
-14% -$19.7K ﹤0.01% 1508
2015
Q3
$155K Buy
+11,739
New +$177K 0.01% 1383
2015
Q2
Sell
-13,133
Closed -$234K 1479
2015
Q1
$234K Sell
13,133
-3,896
-23% -$72.4K 0.01% 1201
2014
Q4
$324K Buy
17,029
+3,205
+23% +$54.3K 0.01% 1004
2014
Q3
$190K Buy
+13,824
New +$197K 0.01% 1208

Other funds holding ANGO

Tudor Investment Corp's ANGO Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in AngioDynamics (ANGO) in Q1 2026: 46,314 shares worth $527K. The stake represents ﹤0.01% of the portfolio and ranks #2782 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in ANGO as recently as Q1 2025.

Tudor Investment Corp first reported a position in ANGO in Q3 2014 and has held it in 29 quarters since. The position peaked at $1.77M in Q1 2022. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Tudor Investment Corp held 46,314 shares of AngioDynamics worth $527K as of Q1 2026.
  • AngioDynamics was a new Tudor Investment Corp position in Q1 2026.
  • AngioDynamics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2782 holding.
  • Tudor Investment Corp first reported a position in AngioDynamics in Q3 2014 and has held it in 29 quarters since.
  • Tudor Investment Corp's AngioDynamics position peaked at $1.77M in Q1 2022.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.